nodes	percent_of_prediction	percent_of_DWPC	metapath
Misoprostol—PTGER4—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.101	0.124	CbGpPWpGaD
Misoprostol—PTGER2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0833	0.102	CbGpPWpGaD
Misoprostol—PTGER3—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0769	0.0942	CbGpPWpGaD
Misoprostol—PTGER4—nervous system—Gilles de la Tourette syndrome	0.0365	0.199	CbGeAlD
Misoprostol—PTGER4—central nervous system—Gilles de la Tourette syndrome	0.0352	0.191	CbGeAlD
Misoprostol—PTGER3—nervous system—Gilles de la Tourette syndrome	0.0309	0.168	CbGeAlD
Misoprostol—PTGER3—central nervous system—Gilles de la Tourette syndrome	0.0298	0.162	CbGeAlD
Misoprostol—PTGER4—brain—Gilles de la Tourette syndrome	0.0279	0.152	CbGeAlD
Misoprostol—PTGER3—brain—Gilles de la Tourette syndrome	0.0236	0.129	CbGeAlD
Misoprostol—PTGER4—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.0167	0.0205	CbGpPWpGaD
Misoprostol—PTGER4—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.0162	0.0199	CbGpPWpGaD
Misoprostol—PTGER4—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.0151	0.0185	CbGpPWpGaD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.0143	0.0175	CbGpPWpGaD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.0139	0.017	CbGpPWpGaD
Misoprostol—PTGER2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.0137	0.0168	CbGpPWpGaD
Misoprostol—PTGER3—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.0136	0.0167	CbGpPWpGaD
Misoprostol—PTGER2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.0133	0.0163	CbGpPWpGaD
Misoprostol—PTGER3—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.0132	0.0162	CbGpPWpGaD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.0129	0.0159	CbGpPWpGaD
Misoprostol—PTGER3—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.0127	0.0155	CbGpPWpGaD
Misoprostol—PTGER2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.0124	0.0152	CbGpPWpGaD
Misoprostol—PTGER3—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.0123	0.0151	CbGpPWpGaD
Misoprostol—PTGER3—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.0123	0.0151	CbGpPWpGaD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.0117	0.0144	CbGpPWpGaD
Misoprostol—PTGER3—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.0114	0.014	CbGpPWpGaD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.0114	0.014	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.0109	0.0133	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.0108	0.0133	CbGpPWpGaD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.0106	0.013	CbGpPWpGaD
Misoprostol—PTGER4—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.0106	0.013	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.0106	0.013	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.0105	0.0129	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00985	0.0121	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.0098	0.012	CbGpPWpGaD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00906	0.0111	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00895	0.011	CbGpPWpGaD
Misoprostol—PTGER2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00868	0.0106	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00868	0.0106	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00826	0.0101	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00809	0.00991	CbGpPWpGaD
Misoprostol—PTGER3—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00801	0.00982	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00801	0.00982	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00747	0.00915	CbGpPWpGaD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00744	0.00912	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.0069	0.00846	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00687	0.00841	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00616	0.00754	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00598	0.00732	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00567	0.00694	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00559	0.00685	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00557	0.00682	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00543	0.00665	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00523	0.00641	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00506	0.0062	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00506	0.00619	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00491	0.00601	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00467	0.00572	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00459	0.00563	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00457	0.0056	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00453	0.00555	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00446	0.00546	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00424	0.00519	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00422	0.00517	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00415	0.00509	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00411	0.00504	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.0039	0.00478	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00383	0.0047	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00354	0.00434	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.0033	0.00405	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00321	0.00393	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.0032	0.00392	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00299	0.00366	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00296	0.00362	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00291	0.00356	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00271	0.00332	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00268	0.00329	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00263	0.00323	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.0025	0.00307	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00245	0.00301	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00243	0.00298	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00226	0.00277	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.00209	0.00256	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.00172	0.0021	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.00159	0.00194	CbGpPWpGaD
